Jacome M, Wu Q, Chen J, Mohamed Z, Mokhtari S, Pina Y
Int J Mol Sci. 2025; 26(5).
PMID: 40076927
PMC: 11900073.
DOI: 10.3390/ijms26052307.
Ziemann C, Cremers F, MacPherson M, Rades D, Loser A
In Vivo. 2025; 39(2):834-843.
PMID: 40010946
PMC: 11884443.
DOI: 10.21873/invivo.13886.
Torner B, Geczi D, Klekner A, Balogh I, Penyige A, Birko Z
Cancers (Basel). 2025; 17(4).
PMID: 40002176
PMC: 11853152.
DOI: 10.3390/cancers17040581.
Upasani M, Shinde P, Veer R
Support Care Cancer. 2024; 33(1):21.
PMID: 39666080
DOI: 10.1007/s00520-024-09058-1.
Tomioka Y, Seki N, Suetsugu T, Hagihara Y, Sanada H, Goto Y
Int J Mol Sci. 2024; 25(18).
PMID: 39337462
PMC: 11432174.
DOI: 10.3390/ijms25189974.
Navigating Brain Metastases: Unveiling the Potential of 3-Tesla Intraoperative Magnetic Resonance Imaging.
Altawalbeh G, Goldberg M, Mondragon-Soto M, Negwer C, Wagner A, Gempt J
Cancers (Basel). 2024; 16(16).
PMID: 39199547
PMC: 11353160.
DOI: 10.3390/cancers16162774.
End-of-Life Care and Use of Hospital Resources in Radiotherapy-Treated Cancer Patients with Brain Metastases: A Single-Institution Retrospective Study.
Nahls N, Anttonen A, Loyttyniemi E, Jekunen A, Akren O, Saarto T
Palliat Med Rep. 2024; 5(1):316-323.
PMID: 39144132
PMC: 11319853.
DOI: 10.1089/pmr.2024.0017.
Assessing survival in non-small cell lung cancer brain metastases after stereotactic radiosurgery: before and after the start of the targetable mutation era.
Cole K, Earl E, Findlay M, Sherrod B, Tenhoeve S, Kunzman J
J Neurooncol. 2024; 169(3):671-681.
PMID: 38951457
DOI: 10.1007/s11060-024-04749-5.
Does 5-ALA Fluorescence Microscopy Improve Complete Resectability in Cerebral/Cerebellar Metastatic Surgery? A Retrospective Data Analysis from a Cranial Center.
Sarkis H, Zawy Alsofy S, Stroop R, Lewitz M, Schipmann S, Unnewehr M
Cancers (Basel). 2024; 16(12).
PMID: 38927947
PMC: 11201798.
DOI: 10.3390/cancers16122242.
Dural Metastasis in Breast Cancer: MRI-Based Morphological Subtypes and Their Clinical Implications.
Ahn S, Joo B, Park M, Park H, Suh S, Ahn S
Cancer Res Treat. 2024; 56(4):1105-1112.
PMID: 38514195
PMC: 11491251.
DOI: 10.4143/crt.2024.138.
Pre-operative vs. post-operative stereotactic radiosurgery for operative metastatic brain tumors: study protocol for a phase III clinical trial.
Routman D, Jusue-Torres I, Brown P, Trifiletti D, Vora S, Brown D
BMC Cancer. 2024; 24(1):332.
PMID: 38475765
PMC: 10929171.
DOI: 10.1186/s12885-024-12060-9.
Case report: Diagnostic challenge: a new multiple sclerosis "relapse" leading to the diagnosis of anaplastic astrocytoma.
Petrasova M, Srotova I, Kolcava J, Stourac P, Hynkova L, Kerkovsky M
Front Neurol. 2024; 14:1324269.
PMID: 38344109
PMC: 10858451.
DOI: 10.3389/fneur.2023.1324269.
Brain metastases and lung cancer: molecular biology, natural history, prediction of response and efficacy of immunotherapy.
Sereno M, Hernandez de Cordoba I, Gutierrez-Gutierrez G, Casado E
Front Immunol. 2024; 14:1297988.
PMID: 38283359
PMC: 10811213.
DOI: 10.3389/fimmu.2023.1297988.
Clinical Application of the Association between Genetic Alteration and Intraoperative Fluorescence Activity of 5-Aminolevulinic Acid during the Resection of Brain Metastasis of Lung Adenocarcinoma.
Jeong H, Suh W, Kim S, Nam T, Jang J, Kim K
Cancers (Basel). 2024; 16(1).
PMID: 38201516
PMC: 10778171.
DOI: 10.3390/cancers16010088.
Automated identification and quantification of metastatic brain tumors and perilesional edema based on a deep learning neural network.
Chou C, Yang H, Chang P, Chen C, Wu H, Lin C
J Neurooncol. 2023; 166(1):167-174.
PMID: 38133789
DOI: 10.1007/s11060-023-04540-y.
Utility of a prognostic assessment tool to predict survival following surgery for brain metastases.
Cuthbert H, Riley M, Bhatt S, Au-Yeung C, Arshad A, Eladawi S
Neurooncol Pract. 2023; 10(6):586-591.
PMID: 38026583
PMC: 10666803.
DOI: 10.1093/nop/npad047.
Health-related quality of life after stereotactic radiosurgery in patients with brain metastases.
Albers E, de Ligt K, van de Poll-Franse L, Compter A, de Ruiter M, Schagen S
Support Care Cancer. 2023; 31(12):720.
PMID: 38008876
DOI: 10.1007/s00520-023-08203-6.
Overall survival following stereotactic radiosurgery for ten or more brain metastases: a systematic review and meta-analysis.
Rozati H, Chen J, Williams M
BMC Cancer. 2023; 23(1):1004.
PMID: 37858075
PMC: 10585836.
DOI: 10.1186/s12885-023-11452-7.
Frailty indices in patients undergoing surgical resection of brain metastases: a systematic review.
Roy J, Bangash A, Skandalakis G, Bowers C
Neurosurg Rev. 2023; 46(1):267.
PMID: 37815634
DOI: 10.1007/s10143-023-02174-2.
Hippocampal avoidance whole brain radiotherapy in brain metastasis using volumetric modulated arc therapy: experience from a Regional Cancer Centre of Eastern India.
Deepsikha G, Maji T, Lahiri D, Roy S, Bhanja S, Rangineni S
Rep Pract Oncol Radiother. 2023; 28(4):468-477.
PMID: 37795235
PMC: 10547418.
DOI: 10.5603/RPOR.a2023.0048.